2-177231801-C-T
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_006164.5(NFE2L2):c.802G>A(p.Val268Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00413 in 1,614,212 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_006164.5 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency, developmental delay, and hypohomocysteinemiaInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Illumina, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00251 AC: 382AN: 152212Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00241 AC: 601AN: 249402 AF XY: 0.00230 show subpopulations
GnomAD4 exome AF: 0.00430 AC: 6284AN: 1461882Hom.: 32 Cov.: 31 AF XY: 0.00415 AC XY: 3020AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00251 AC: 382AN: 152330Hom.: 1 Cov.: 32 AF XY: 0.00227 AC XY: 169AN XY: 74492 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
NFE2L2: BP4, BS2 -
- -
NFE2L2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not specified Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at